| Literature DB >> 34221863 |
Yang Yu1,2, Changliang Yao1, De-An Guo1,2.
Abstract
Traditional Chinese medicine (TCM) has been an indispensable source of drugs for curing variousEntities:
Keywords: BS, background subtraction; CCS, collision cross section; CE, collision energy; CID, collision-induced dissociation; DDA, data-dependent acquisition; DE, dynamic exclusion; DIA, data-independent acquisition; DIF, diagnostic ion filtering; DM, database matching; Data acquisition; Data post-processing; EL, exclusion list; EMS, enhanced mass spectrum; EPI, enhanced product ion; FS, full scan; HCD, high-energy C-trap dissociation; IDA, information dependent acquisition; IM, ion mobility; IPF, isotope pattern filtering; ISCID, in-source collision-induced dissociation; LC, liquid chromatography; LTQ-Orbitrap, linear ion-trap/orbitrap; Liquid chromatography−mass spectrometry; MDF, mass defect filtering; MIM, multiple ion monitoring; MN, molecular networking; MRM, multiple reaction monitoring; MS, mass spectrometry; MTSF, mass spectral trees similarity filter; NL, neutral loss; NLF, neutral loss filtering; NLS, neutral loss scan; NRF, nitrogen rule filtering; PCA, principal component analysis; PIL, precursor ion list; PIS, precursor ion scan; PLS-DA, partial least square-discriminant analysis; Q-TRAP, hybrid triple quadrupole-linear ion trap; QSRR, quantitative structure retention relationship; QqQ, triple quadrupole; Qualitative analysis; RT, retention time; SA, statistical analysis; TCM, traditional Chinese medicine; Traditional Chinese medicine; UHPLC, ultra-high performance liquid chromatography; cMRM, conventional multiple reaction monitoring; sMRM, scheduled multiple reaction monitoring
Year: 2021 PMID: 34221863 PMCID: PMC8245813 DOI: 10.1016/j.apsb.2021.02.017
Source DB: PubMed Journal: Acta Pharm Sin B ISSN: 2211-3835 Impact factor: 11.413
Figure 1Data acquisition and data post-processing techniques of LC−MS in TCM qualitative analysis. PIL, precursor ion list; DE, dynamic exclusion; PIS, precursor ion scan; NLS, neutral loss scan; MRM, multiple reaction monitoring; MDF, mass defect filtering; BS, background subtraction; IPF, isotope pattern filtering; DIF, diagnostic ion filtering; NLF, neutral loss filtering; MTSF, mass spectral trees similarity filter, MN: molecular networking; SA, statistical analysis; DM, database matching.
Applications of LC−MS in TCM qualitative analysis.
| TCM sample | Mass analyzer | Data acquisition technique | Data post-processing technique | Characterization result | Ref. |
|---|---|---|---|---|---|
| Q-TOF | MSAll; SWATH | DIF | 89 triterpene saponins, along with 14 sapogenins, including 33 potentially new compounds and the first report of malonyl-saponin in genus | ||
| Q-TOF | IMS-MSE | DM; NLF | 121 lanostane-type triterpene acids, including three new compounds | ||
| Yi-Xin-Shu capsule | Q-TOF | PIL-MS/MS | DIF | 276 compounds, including 50 lignans, 30 tanshinones, 4 lactones, 18 flavones, 14 phenolicacids, 1 triterpenoid acid, 3 ophiopogonins, 7 astragalus saponins, and 149 ginsenosides | |
| Erzhi pill | Q-Orbitrap | Full MS/PIL/dd-MS2; “If idle-pick others” (IIPO); DE | MDF; NLF; DIF | 146 components, including 25 triterpenes, 31 flavonoids, 46 iridoids, 16 phenylethanols, 3 coumarins, 12 phenols, and 13 others | |
| LTQ-Orbitrap | PIL-DE-CID/MS2-HCD/MS3 | BS; MDF; DM | 158 potentially new alkaloids, including 10 unknown but predicted and 108 unexpected ones | ||
| Three different parts (the root, stem leaf, and flower bud) of | Q-Orbitrap | Full MS/PIL/IIPO/dd-MS2; DE | MDF | 347 saponins (147 from root, 173 from stem leaf, and 195 from flower bud), and 157 thereof not ever-isolated from the | |
| LTQ-Orbitrap | PIL; DE | NLF | 66 compounds, including 43 malonates of isoflavone glycoside | ||
| LTQ-Orbitrap | ISCID-FS; PIL-HCD-MS/MS; DE | NLF | 101 malonyl-ginsenosides, including 69 from | ||
| LTQ-Orbitrap | HCD-MS2; PIL-CID-MS4; FS-MS | MN; DM | 106 triterpene saponins including 49 potentially new ones | ||
| Q-Orbitrap | full MS/PIL/dd-MS2; IIPO; DE | Retention behavior; Reference compounds comparison; Elemental composition analysis; Fragmentation pathways interpretation; DM | 13 primary metabolites (1 nucleoside, 2 sugars, 5 organic alkali/acids, and 5 amino acids) and 135 secondary metabolites (97 quinochalcone | ||
| Ligustri Lucidi Fructus | Q-Orbitrap | Full MS/PIL/dd-MS2; IIPO; DE; Polarity switching | Reference compounds comparison; Elemental composition analysis; Fragmentation pathways analysis; DM | 158 components, including 137 in the negative mode and 21 in the positive mode | |
| LTQ-Orbitrap | FS-PIL-DE | DIF | 135 polymethoxylated flavonoids, including 81 polymethoxyflavones, 54 polymethoxyflavanones or polymethoxychalcones | ||
| LTQ-Orbitrap | PIL-MS | Predicted compounds filtering; Total ion chromatogram filtering; Fragment ion search | 190 polymeric phenolic acids, including 18 first detected ones | ||
| Lonicerae Japonicae Flos | Q-Obitrap | EL-dd-MS2 | DM; MN | A total of 537 compounds, including a large number of potential novel structures | |
| LTQ-Orbitrap | FS-DE-MS1; HCD-MS2 (−); CID-MS2 (−); CID-MS3 (−); Product ion-MS4 (−); CID-MS2 (+); NL-MS3 (+) | – | 78 dicarboxylic acid conjugated bufotoxins, including 68 new compounds, 25 types of substructure formulas and seven dicarboxylic acid side chains | ||
| Roots, leaves, and flower buds of | LTQ-Orbitrap | ISCID-FS-MS1; Mass tag/CID-MS2; NLS/HCD-MS3; DE | – | 178 malonylginsenosides | |
| LTQ-Orbitrap | ISCID-FS-MS1; Mass tag/CID-MS2; Product ion scan/CID-MS3; DE | NLF | 216 carboxyl-free ginsenosides | ||
| Processed | QTOF; QqQ | PIS | – | 24 benzoyl-containing alkaloids | |
| Q-TRAP | PIS | – | 10 caffeoylquinic acid derivatives | ||
| QqQ; QTOF | PIS; Product ion scan | – | 74 oplopane- and bisabolene- sesquiterpenoids, and isolation of 11 compounds | ||
| QqQ; QTOF | NLS; PIS | – | 50 triterpene saponins | ||
| QqQ | PIS; FS; Product ion scan | DIF; NLF | 110 polyoxypregnane and its glycosides | ||
| QqQ | Two-step PIS | – | 17 flavonoids, including 9 newly identified ones | ||
| Danhong injection | QTRAP | EMS-IDA-EPI; PIS-IDA-EPI | DM | 90 compounds, including 46 salvianolic acids and related phenolic compounds | |
| QTRAP; QTOF | EMS-EPI; Stepwise MIM-EPI; PIS-EPI | NLF | 48 naphthoquinones including 24 novel ones | ||
| Radix Glehniae | QTRAP | MIM-IDA-EPI; PIS-IDA-EPI | – | 41 coumarins | |
| QTRAP | EMS-IDA-EPI; Predefined MRM-IDA-EPI; PIS-IDA-EPI; NL-IDA-EPI | DM | 513 components detected, including 379 annotated compounds | ||
| Tobacco leaves | QqQ | NLS; Product ion scan | DM | 64 glycosides, including 39 glycosides linked with monosaccharides, 18 glycosides linked with disaccharides and 7 glycosides linked with trisaccharides | |
| Astragali Radix (Huangqi) | QTRAP | MIM-EPI; PI-EPI; NL-EPI; MRM-EPI | Extracted ion chromatogram; DIF; NLF | 421 flavonoids | |
| Astragali Radix | QTRAP | NL/PIS-IDA-enhanced resolution-EPI | – | 136 triterpenoid saponins | |
| QTRAP | NLS | – | 27 sulfated flavonoids | ||
| Ion trap | FS; MS | DIF; NLF | 77 flavonoid glycosides | ||
| Alismatis Rhizoma and processed Alismatis Rhizoma | QTOF; QTRAP | FS; MS/MS; MRM | DIF; NLF | 80 triterpenes including 14 novel compounds; 7 more triterpenes compounds in the processed | |
| QTRAP | MRM-IDA-EPI | – | 27 components, including eighteen diterpenoids, six phenolic acids, and three flavonoids | ||
| Turmeric | TripleTOF; QTRAP | CID-MS/MS; MRM-EPI | BS; DIF; Ring double bond equivalents calculation | 96 curcuminoids | |
| Ginseng, American ginseng, and processed products | QTRAP | Step-wise MRM-IDA-EPI; sMRM | PCA | 221 ginsenosides, including 185 annotated ones | |
| Shenfu injection | QTRAP | Predefined MRM-IDA-EPI; Step-wise MIM-IDA-EPI | DM | 157 detected hydrophilic compounds, and 154 of which were identified as amino acids, nucleosides, organic acid, carbohydrates, etc.; 40 primary hydrophilic and hydrophobic ingredients including 11 amino acids, 9 nucleosides, 9 aconite alkaloids, and 11 ginsenosides | |
| LTQ-Orbitrap | FS-MS1; CID-MS2; CID-MS3; DE-HCD-MS/MS | DIF; Ring double bond equivalent; Characteristic UV absorption; Diagnostic product ions analysis | 163 quinochalcone | ||
| LTQ-Orbitrap | CID-MS1-MS2-MS3; DE-HCD-MS1-MS2 | DIF; NLF; DM | 107 flavonoids, including 80 newly reported flavonoid | ||
| Q-TOF; IT-TOF | FS; MS1-MS2-MS3 | MDF | More than 50 ophiopogonins and 27 ophiopogonones | ||
| Yin Chen Si Ni Tang | Q-TOF | MSE | MDF | 62 | |
| LTQ-Orbitrap | DE-CID-MS4 | MDF; NLF; DIF; DM | 92 alkaloids (60 free alkaloids and 32 alkaloid | ||
| Processed Semen Strychni | IT-TOF | FS; MS2 and MS3 | MDF; DIF | 24 dihydroindole-type alkaloids, including 4 that were previously not described | |
| LTQ-Orbitrap | MS and MS/MS | MDF; DIF | 81 polymethoxylated flavonoids, including 50 polymethoxyflavones and 31 polymethoxyflavanones or polymethoxychalcones | ||
| Folium Artemisiae Argyi | Q-Orbitrap | FS; MS/MS | NRF; MDF; NLF; DIF | 16 methoxylated flavonoids and 55 chlorogenic acids analogues | |
| Q-TOF | MS; Auto MS/MS; targeted MS/MS | MDF; Characteristic isotopic distribution | 234 ginsenosides including 67 potential new ones | ||
| Five botanical origins of Uncariae Ramulus Cum Unicis | LTQ-Orbitrap | DE-step-wise PIL-CID/MS2-HCD/MS3 | Elemental composition analysis; NLF; DIF; DM | 1227 indole alkaloids | |
| Er-xian decoction | LTQ FT | FS; DE-CID-MS2; CID-MS3 | MTSF; Discriminant analysis; BS | 553 potential compounds and 66 candidates | |
| Arnebiae Radix | Q-Orbitrap | Full MS; MS/MS | BS; DM; MDF | 96 compounds, 13 of which were confirmed by the reference standards, 30 with a low abundance, and 9 unknowns | |
| LTQ-Orbitrap | FS; DDA | IPF | 12 | ||
| Q-TOF | MSE; CID-MS/MS | DIF | 8 potentially new C6–C2 glucoside conjugates | ||
| Zicao | Q-TOF | MS; MS/MS | BS; DIF; Characteristic product ion filtering | 58 compounds including 32 novel ones | |
| Akebiae Fructus | Q-TOF | MSE | Adduct ion filtering; DIF; Characteristic ion filtering; NLF | 94 compounds (85 triterpenoid saponins and 9 chlorogenic acids), including 9 types of triterpenoid saponins and 2 types of chlorogenic acid; 50 newly discovered constituents | |
| Q-TOF | FS in both positive and negative modes; (−)-MS/MS | DM; DIF | 38 compounds, including 36 flavonoids and 2 non-flavonoid compounds | ||
| Q-Orbitrap | FS; MS/MS | DIF | 132 compounds, 59 of which were reported for the first time | ||
| LTQ-Orbitrap | FS; MS/MS | DIF | 21 molecules, 17 of which were found to belong to the targeted chemical groups, including 8 isoflavones, 7 dihydroisoflavones and 2 isoflavone glycosides | ||
| Roots and berries of raw and steamed American ginseng ( | TOF; Q-TOF | FS; CID-MS/MS | DIF | 70 saponins | |
| Fresh and processed ginseng | Q-TOF | FS; CID-MS/MS | DIF; NLF | 12 malonyl ginsenosides | |
| Q-TOF | MS; MS/MS | DIF | A total of 29 compounds, comprising 18 alkaloids, 6 flavonoids, and 5 quinic acids; 4 novel tetracyclic monoterpenoid oxindole alkaloids (TMOAs) | ||
| Q-TOF | MS; MS/MS | DIF | 37 lycorine-type alkaloids, including 16 previously undescribed compounds | ||
| Calyx of | Q-TOF | MS; MS/MS | DIF; NLF | 46 physalins, including 20 novel ones | |
| Glechomae Herba | Q-TOF | MS; MS/MS | DIF; NLF | 120 compounds, including 10 chlorogenic acids, 10 gallic acids, 21 phenylpropionic acids and 77 flavonoids; 65 newly discovered constituents; 4 types of chlorogenic acids, 3 types of galloylglucoses, 3 types of phenylpropionic acid skeletons, and 5 types of flavonoid aglycone skeletons | |
| Raw and processed pieces of | Q-TOF | (−)-MS; (−)-MS/MS | DM; DIF | 73 characteristic markers | |
| QTOF | MS/MS; ISCID MS/MS; ISCID combined with TAP fragmentation; IM-MSE; IM-MS/MS | DIF | 140 potential polycyclic polyprenylated acylphloroglucinols (PPAPs), including 7 pairs coeluting isobaric PPAPs that were indistinguishable by conventional UHPLC−HRMS alone | ||
| Shengmai injection | IT-TOF | MS1, MS2, MS3 | DIF | More than 30 ginsenosides and 20 lignans | |
| Guge Fengtong tablet | Q-TOF | FS | DIF | 47 components, including 18 phenolic acids, 8 saponins, 14 gingerol-related compounds, and 7 diarylhepatonoids | |
| Yindan Xinnaotong soft capsule | Q-TOF; QqQ | FS; MRM | DM; DIF; MDF; NLF | 124 compounds, including 44 flavonoids, 31 phenolic acids, 20 tanshi-nones, 16 saponins, 6 ginkgolides, 5 sulfides, camphor and borneol | |
| Roots of | LTQ-Orbitrap | FS; CID-MS2-MS3 | NLF | 42 diester-diterpenoid alkaloids; 23 potential new compounds, including 16 short chain fatty acyls diester-diterpenoid alkaloids, 4 | |
| LTQ FT | DE-CID-MS3 | MTSF | 38 compounds, including 19 flavones, 11 phenylpropanoids and 8 sphingolipids; among them, 7 flavonoids, 8 phenylpropanoids and 8 sphingolipids were identified for the first time in | ||
| LTQ-Orbitrap | FS; CID-MS2; DE | MTSF | 47 chlorogenic acids, including 19 monoacyl-quinic acids, 22 diacyl-quinic acids, and six triacyl-quinic acids | ||
| Flos Lonicerae Japonicae | LTQ-Orbitrap | FS; FS-PIL; MIM | DM; MTSF; DIF | 115 chlorogenic acids attributed to 18 categories, most of which were newly reported | |
| Xiao-Xu-Ming decoction | LTQ FT | FS; DE-CID-MS2; CID-MS3 | MTSF | 68 compounds among 3362 detected compounds, including 14 templated compounds (reference compounds), 50 related compounds fished by MTSF technique, and 4 unrelated compounds identified by manual method | |
| Venenum Bufonis | Q-TOF | Fast DDA | MN | 229 bufadienolides, including two subclasses of compounds (bufogeninsconjugated with carboxylic acid and | |
| Aconiti Lateralis Radix Praeparata and its processed products | Q-TOF | MSE | MN | 145 diterpenoid alkaloids, including 78 C19 (19 diester-diterpenoid alkaloids, 20 monoester-diterpenoid alkaloids, 7 lipo-diterpenoid alkaloids, 32 amine-diterpenoid alkaloids), 13 C20, and 54 other diterpenoid alkaloids | |
| Danhong injection | Q-Orbitrap | FS | SA | 117 compounds, including 76 phenolic acids, 20 flavonoids, and 21 other compounds | |
| QqQ | NL/PIS | SA | 846 terpecurcumins (terpene-conjugated curcuminoids), including a number of potentially novel compounds | ||
| Q-TOF | MS; MS/MS | DIF; NLF; SA | 87 phenylethanoid glycosides, including 14 isomers | ||
| Ziziphi Spinosae Semen and Ziziphi Mauritianae Semen | Q-TOF | MSE | DM; DIF; NLF | 60 target components in Ziziphi Spinosae Semen, including 27 flavonoids, 16 saponins, 10 alkaloids, 6 terpenes, and 1 other, and 53 nontarget components with 40 new deduced components; 132 chemical components in Ziziphi Mauritianae Semen, including 7 additional nontarget new components | |
| Peanut stems and leaves | Q-TOF | MSE | DM | 283 chemical compounds, including 207 new compounds | |
| White and red ginsengs | Q-TOF | IM-MSE; IM-MS/MS | DM | 201 ginsenosides, including 10 pairs of co-eluting isobaric ginseng saponins | |
| Stems and leaves of | LTQ-Orbitrap | DE-CID-MS3; DE-HCD-MS2 | NLF; DIF; DM | 646 ginsenosides, including 427 which have not been isolated from the genus of | |
| Five different parts (root, leaf, flower bud, berry, and seed) of | Q-TOF | MSE | DM | 164 compounds | |
| Q-TOF | Fast DDA | DM; DIF; NLF | 945 ginsenosides, including 662 potentially novel ginsenosides | ||
| Baoyuan decoction | Q-TOF; QTRAP | FS-MS1; MSE; Predefined MRM-EPI, MIM-EPI, and PIS-EPI | DM; DIF | 236 compounds, including 139 saponins, 83 flavonoids, 6 procyanidins, 4 lignans, and 4 diterpenes | |
| Q-TOF | MSE | DM | 146 metabolites, including 42 potential new compounds | ||
| Q-TOF | MSE; HDMSE | DM | 24 potential lipid markers enabling the simultaneous differentiation of three | ||
| LTQ-Orbitrap | FS-HRMS; MS/MS; DE | DM; Parent mass modification search; DIF; MTSF | 69 phenylethanoid glycosides, including 17 new ones | ||
| Q-TOF | MS; MS/MS | DM | 148 lipo-alkaloids, including 93 potential new compounds and 38 compounds with oxygenated fatty acid moieties | ||
| Q-TOF | MS/MS | DM | 57 components, including 43 alkaloids, 9 iridoids, 2 steroids, 2 phenolic acids and 1 coumarin |
Selection criteria of data acquisition and post-processing techniques in TCM qualitative analysis.
| Technique | Advantage | Limitation | Scope of application | |
|---|---|---|---|---|
| DIA | DIA | Full coverage of MS1 and MS2 information | Loss link between precursor and product ions | Acquisition of MS/MS information of minor or trace compounds |
| DDA | PIL | Screening of only (or preferred) target ions in the list | Miss of novel compounds with new sub-structures or substituted groups | Target compounds with predictable molecular weights and/or |
| DE | Detection of less abundant co-eluting ions | Quality loss of MS2 information of abundant ions | MS/MS information of both abundant and less abundant compounds in complex samples | |
| Mass tag | Selective screening of compounds that undergo in-source fragmentations | Not applicable to relatively stable compounds that cannot generate certain in-source fragmentation patterns | Compounds that can undergo certain in-source fragmentations with ISCID energy | |
| PIS | Requirements of little prior-knowledge about the exact structure of target compounds | Miss of compounds without selected product ions | Compounds with known specific product ions | |
| NLS | Targeted screening of modified or conjugated compounds that undergo neutral eliminations | Only compounds with certain neutral eliminations | Compounds with certain neutral eliminations | |
| MRM | High selectivity and sensitivity in screening target compounds | Low resolution and unable to screen unknown compounds without information of parent and product ions | Target compounds with known parent and product ions | |
| Data post-processing | MDF | Selective screening of certain compounds or compound classes and remove of interferences | Requirements of a carefully-designed appropriate MDF region | Compounds with predictable mass range and mass defect range |
| BS | Elimination of background signals, and exposure of target compounds | Poor selectivity of target compounds | Severe background interferences | |
| IPF | Specific screening of compounds with certain elements | Relatively narrow application scope | Compounds with distinct isotope pattern | |
| DIF | Rapid screening of target compounds that produce identical product ions | Miss of compounds without selected product ions | Compounds with known product ion | |
| NLF | Compounds that undergo neutral eliminations | Only compounds with certain neutral eliminations | Compounds with specific neutral loss | |
| MTSF | Rapid classification and characterization of unknown compounds | Need of MS | Target compounds sharing the same sub-structures and similar MS | |
| MN | Rapid classification and characterization of compounds without prior knowledge of the chemical structures | Manual interpretation of detailed structure information of unknown compounds based on the related known compounds | Compounds with MS/MS spectra | |
| SA | Rapid exploration of intrinsic relationships between compound structures and MS data | Further characterization and identification of compounds | Recognition of potential characteristic ions, discrimination of different structures and isomers | |
| DM | Alleviation of labor for mining structural information from large-scale datasets | Limited records in databases and requirements of further manual confirmation | Automatic search and annotation of compounds through on-line or in-house databases | |
Figure 2A decision tree that represents a possible way to select an LC–MS based data acquisition/post-processing strategy.